| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03c0ce63b2c055d9018380e72f995b26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62fde05e7fbae261f442cd6011f4e379
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a37d4d66983bbb53a29667d5d9a5a1ae |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-1055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-1065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-064 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-00 |
| filingDate |
2007-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b15583e8eb59224c738e8254b4f77bcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_084e5d0dc5a1769c4074923b08bfd58d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_062bd0cef14eeb93d886de5f6669ddb3 |
| publicationDate |
2010-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010269819-A1 |
| titleOfInvention |
Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions |
| abstract |
In one embodiment, a human-powered dry powder inhaler comprises a human-powered compressible component operable to discharge an air pulse at an outlet at a pressure of about 1-40 psi; an inflatable reservoir operable to receive an air pulse discharged from the human-powered compressible component to provide an aerosol of a dry powder pharmaceutical formulation in the reservoir, the reservoir including an outlet valve; and a receiving mask in communication with the outlet valve and operable to receive an aerosol of dry powder from the reservoir and to deliver the aerosol to at least a mouth or nose of a patient. In another embodiment, the inhaler comprises a human-powered compressible component operable to discharge an air pulse at an outlet of a polymeric pressure release valve at a pressure of about 1-40 psi; and a receiving mask in communication with the outlet of the compressible component and operable to deliver an aerosol of dry powder to at least a mouth or nose of a patient. Methods for delivery of a dry powder pharmaceutical formulation to a patient are conducted in the absence of electrical power and circuitry and pre-pressurized propellant gas. Suitable dry powder pharmaceutical formulations may include myo-inositol and/or maltodextrin as a carrier and active ingredients such as vaccines or siRNA. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011120465-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9010323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023010180-A1 |
| priorityDate |
2006-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |